Nutex Health Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Nutex Health Inc. has filed 529 SEC EDGAR filings since 31 Dec 2009

SEC filing history

Showing 401-425 of 528 matching filings.

Per page
25
Current page
17
3

PRIMARY DOCUMENT

Filing date
13 Sep 2017
Reporting date
01 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
13 Sep 2017
Reporting date
14 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
13 Sep 2017
Reporting date
14 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-53862

NT 10-Q

Filing date
14 Aug 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

IGAMBIT 8.K ACQUISITION

Filing date
06 Jul 2017
Reporting date
05 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53862

IGAMBIT 10-Q MARCH 2017

Filing date
22 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
NT 10-Q File 000-53862

IGAMBIT EXT FILING 10Q MARCH 2017

Filing date
15 May 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85387

AMENDMENT NO. 4

Filing date
10 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

IGAMBIT 8-K DR BENEDICT

Filing date
08 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-53862

IGAMBIT 10-K DEC 31ST 2016

Filing date
17 Apr 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
8-K File 000-53862

IGAMBIT CYBERCARE 8-K APR 6TH 2017

Filing date
06 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

IGAMBIT 8-K MATERIAL DEFINITIVE AGREEMENT

Filing date
05 Apr 2017
Reporting date
05 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-53862

IGAMBIT EXT FILING 10-K DEC 2016

Filing date
31 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

IGAMBIT 8-K HUBCENTRIX AGREEMENT

Filing date
15 Feb 2017
Reporting date
15 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

SALE OF STOCK

Filing date
31 Jan 2017
Reporting date
31 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53862

IGAMBIT 10-Q SEPT 2016

Filing date
21 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
NT 10-Q File 000-53862

IGAMBIT EXT FILING SEPT 2016

Filing date
14 Nov 2016
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

IGAMBIT 8-K NEW CEO

Filing date
24 Oct 2016
Reporting date
24 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

8-K filing

Filing date
19 Sep 2016
Reporting date
19 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85387

AMENDMENT NO. 3

Filing date
08 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53862

IGAMBIT 8-K LETTER OF INTENT

Filing date
26 Aug 2016
Reporting date
26 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53862

IGAMBIT 10-Q JUNE 2016

Filing date
22 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
8-K File 000-53862

LETTER OF INTENT

Filing date
15 Aug 2016
Reporting date
15 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .